GT
NVRO

Glenmede Trust’s NEVRO CORP. NVRO Stock Holding History

Glenmede Trust’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40
Closed -$5K – 2320
2020
Q3 		$5K Hold
40
– – ﹤0.01% 2109
2020
Q2 		$4K Hold
40
– – ﹤0.01% 2146
2020
Q1 		$4K Hold
40
– – ﹤0.01% 2737
2019
Q4 		$4K Hold
40
– – ﹤0.01% 2737
2019
Q3 		$3K Sell
40
-1,275
-97% -$96.5K ﹤0.01% 2798
2019
Q2 		$85K Buy
1,315
+275
+26% +$17.1K ﹤0.01% 1462
2019
Q1 		$65K Buy
1,040
+1,000
+2,500% +$47K ﹤0.01% 1565
2018
Q4 		$1K Buy
+40
New +$1.78K ﹤0.01% 2938
2018
Q2 		– Sell
-3,447
Closed -$237K – 2365
2018
Q1 		$237K Hold
3,447
– – ﹤0.01% 1125
2017
Q4 		$237K Buy
+3,447
New +$276K ﹤0.01% 1125

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Glenmede Trust's NVRO Position: Q4 2020 in Review

Glenmede Trust sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 40 shares — an estimated $5K sold.

Glenmede Trust first reported a position in NVRO in Q4 2017 and held it in 10 quarters. The position peaked at $237K in Q1 2018. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

  • Glenmede Trust reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 40 NEVRO CORP. shares in Q4 2020, an estimated $5K.
  • Glenmede Trust first reported a position in NEVRO CORP. in Q4 2017 and held it in 10 quarters.
  • Glenmede Trust's NEVRO CORP. position peaked at $237K in Q1 2018.
  • 226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.